TGF-β induces Wnt10b in osteoclasts from female mice to enhance coupling to osteoblasts

Endocrinology

Volumn 154, Issue 10, 2013, Pages 3745-3752

  Ota, Kuniaki ^a   Quint, Patrick ^a   Ruan, Ming ^a   Pederson, Larry ^a   Westendorf, Jennifer J ^a,b   Khosla, Sundeep ^a   Oursler, Merry Jo ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 6; PROTEIN KINASE B; SMAD2 PROTEIN; SMAD3 PROTEIN; SPHINGOSINE 1 PHOSPHATE; TRANSFORMING GROWTH FACTOR BETA1; WNT10B PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MINERALIZATION; BONE TURNOVER; CONTROLLED STUDY; DROSOPHILA; EXTRACELLULAR MATRIX; FEMALE; IN VITRO STUDY; MESENCHYME CELL; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WNT SIGNALING PATHWAY;

ANIMALS; ANIMALS, NEWBORN; BONE MORPHOGENETIC PROTEIN 6; CALCIFICATION, PHYSIOLOGIC; CELL COMMUNICATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; FEMALE; GENE EXPRESSION REGULATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYSOPHOSPHOLIPIDS; MICE; MICE, INBRED C57BL; OSTEOBLASTS; OSTEOCLASTS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD PROTEINS, RECEPTOR-REGULATED; SPHINGOSINE; TRANSFORMING GROWTH FACTOR BETA1; WNT PROTEINS;

EID: 84884681701     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1272     Document Type: Article

References (33)

1. Zhao C, Irie N, Takada Y, et al. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab. 2006;4:111-121. (Pubitemid 44138718)
2. Pederson L, Ruan M, Westendorf JJ, Khosla S, Oursler MJ. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci U S A. 2008;105:20764-20769.
3. Tang Y, Wu X, Lei W, et al. TGF-β1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med. 2009;15:757-765.
4. Janssens K, ten Dijke P, Janssens S, Van Hul W. Transforming growth factor-β1 to the bone. Endocr Rev. 2005;26:743-774.
5. Mukherjee A, Larson EA, Carlos AS, Belknap JK, Rotwein P, Klein RF. Congenic mice provide in vivo evidence for a genetic locus that modulates intrinsic transforming growth factor β1-mediated signaling and bone acquisition. J Bone Miner Res. 2012;27:1345-1356.
6. Oursler MJ. Osteoclast synthesis and secretion and activation of latent transforming growth factor β. J Bone Miner Res. 1994;9:443-452. (Pubitemid 24090325)
7. Huang W, Yang S, Shao J, Li YP. Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front Biosci. 2007;12:3068-3092.
8. Kanaan RA, Kanaan LA. 2006 Transforming growth factor β1, bone connection. Med Sci Monit. 12:RA164-RA169. (Pubitemid 44186388)
9. Hock JM, Canalis E, Centrella M. Transforming growth factor-B stimulates bone matrix apposition and bone cell replication in cultured fetal rat calvariae. Endocrinology. 1990;126:421-425.
10. Robey P, Young M, Flanders K, et al. Osteoblasts synthesize and respond to transforming growth factor-type B (TGF-B) in vitro. Cell Biol. 1987;105:457-463. (Pubitemid 17101259)
11. Nistala H, Lee-Arteaga S, Smaldone S, Siciliano G, Ramirez F. Extracellular microfibrils control osteoblast-supported osteoclastogenesis by restricting TGFβ stimulation of RANKL production. J Biol Chem. 2010;285:34126-34133.
12. 1 in osteoclast differentiation and survival. J Cell Sci. 2000;113(Pt 13):2445-2453.
13. Fiorelli G, Ballock RT, Wakefield LM, et al. Role for autocrine TGF-β1 in regulating differentiation of a human leukemic cell line toward osteoclast-like cells. J Cell Physiol. 1994;160:482-490.
14. Karst M, Gorny G, Galvin RJ, Oursler MJ. Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-β regulation of osteoclast differentiation. J Cell Physiol. 2004;200:99-106. (Pubitemid 38720625)
15. Zheng MH, Fan Y, Wysocki SJ, et al. Gene expression of transforming growth factor-β1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration. Am J Pathol. 1994;145:1095-1104. (Pubitemid 24345657)
16. Subramaniam M, Gorny G, Johnsen SA, et al. TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro. Mol Cell Biol. 2005;25:1191-1199. (Pubitemid 40165824)
17. Oursler MJ, Cortese C, Keeting P, et al. Modulation of transforming growth factor-β production in normal human osteoblast-like cells by 17β-estradiol and parathyroid hormone. Endocrinology. 1991;129:3313-3320.
18. Foley JP, Lam D, Jiang H, et al. Toll-like receptor 2 (TLR2), transforming growth factor-β, hyaluronan (HA), and receptor for HA-mediated motility (RHAMM) are required for surfactant protein A-stimulated macrophage chemotaxis. J Biol Chem. 2012;287:37406-37419.
19. Suzuki K, Maruya M, Kawamoto S, et al. The sensing of environmental stimuli by follicular dendritic cells promotes immunoglobulin A generation in the gut. Immunity. 2010;33:71-83.
20. Waghabi MC, Keramidas M, Bailly S, et al. Uptake of host cell transforming growth factor-β by Trypanosoma cruzi amastigotes in cardiomyocytes: potential role in parasite cycle completion. Am J Pathol. 2005;167:993-1003. (Pubitemid 41416252)
21. Zamiri P, Masli S, Kitaichi N, Taylor AW, Streilein JW. Thrombospondin plays a vital role in the immune privilege of the eye. Invest Ophthalmol Vis Sci. 2005;46:908-919. (Pubitemid 41321027)
22. Fichorova RN, Bajpai M, Chandra N, et al. Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives. Biol Reprod. 2004;71:761-769. (Pubitemid 39108635)
23. Liu BY, Wu PW, Bringhurst FR, Wang JT. Estrogen inhibition of PTH-stimulated osteoclast formation and attachment in vitro: involvement of both PKA and PKC. Endocrinology. 2002;143:627-635. (Pubitemid 34107218)
24. Gingery A, Bradley E, Shaw A, Oursler MJ. Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survival. J Cell Biochem. 2003;89:165-179. (Pubitemid 36459107)
25. Gingery A, Bradley EW, Pederson L, Ruan M, Horwood NJ, Oursler MJ. TGF-β coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival. Exp Cell Res. 2008;314:2725-2738.
26. Erlebacher A, Filvaroff EH, Ye JQ, Derynck R. Osteoblastic responses to TGF-β during bone remodeling. Mol Biol Cell. 1998;9:1903-1918. (Pubitemid 28337531)
27. Filvaroff E, Erlebacher A, Ye J, et al. Inhibition of TGF-β receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. Development. 1999;126:4267-4279. (Pubitemid 29509342)
28. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β. Nat Med. 1996;2:1132-1136.
29. Geiser AG, Zeng QQ, Sato M, Helvering LM, Hirano T, Turner CH. Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-β1 gene. Bone. 1998;23:87-93. (Pubitemid 28379868)
30. Atti E, Gomez S, Wahl SM, Mendelsohn R, Paschalis E, Boskey AL. Effects of transforming growth factor-β deficiency on bone development: a Fourier transform-infrared imaging analysis. Bone. 2002;31:675-684. (Pubitemid 36092090)
31. Janssens K, Gershoni-Baruch R, Guañabens N, et al. Mutations in the gene encoding the latency-associated peptide of TGF-β1 cause Camurati-Engelmann disease. Nat Genet. 2000;26:273-275.
32. Loeys BL, Chen J, Neptune ER, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet. 2005;37:275-281. (Pubitemid 41716254)
33. Matt P, Schoenhoff F, Habashi J, et al. Circulating transforming growth factor-β in Marfan syndrome. Circulation. 2009;120:526-532.